358
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs

, MBA BPharm, , , , , , , , & show all
Pages 299-307 | Published online: 12 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fabrizio Esma, Marco Salvini, Rossella Troia, Mario Boccadoro, Alessandra Larocca & Chiara Pautasso. (2017) Melphalan hydrochloride for the treatment of multiple myeloma. Expert Opinion on Pharmacotherapy 18:11, pages 1127-1136.
Read now
Dennis W. Raisch, John A. Rafi, Cheng Chen & Charles L. Bennett. (2016) Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA’s adverse event reporting system. Expert Opinion on Drug Safety 15:8, pages 1003-1011.
Read now
Rasha M Arabyat, Dennis W Raisch, June M McKoy & Charles L Bennett. (2015) Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration’s adverse event reporting system. Expert Opinion on Drug Safety 14:11, pages 1653-1660.
Read now

Articles from other publishers (6)

Mohamed Fizur Nagoor Meeran, Seenipandi Arunachalam, Sheikh Azimullah, Dhanya Saraswathiamma, Alia Albawardi, Saeeda Almarzooqi, Niraj Kumar Jha, Sandeep Subramanya, Rami Beiram & Shreesh Ojha. (2023) α-Bisabolol, a Dietary Sesquiterpene, Attenuates Doxorubicin-Induced Acute Cardiotoxicity in Rats by Inhibiting Cellular Signaling Pathways, Nrf2/Keap-1/HO-1, Akt/mTOR/GSK-3β, NF-κB/p38/MAPK, and NLRP3 Inflammasomes Regulating Oxidative Stress and Inflammatory Cascades. International Journal of Molecular Sciences 24:18, pages 14013.
Crossref
Eric P Borrelli & Conor G McGladrigan. (2020) Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials. Journal of Oncology Pharmacy Practice 27:4, pages 887-896.
Crossref
Qing Shan, Xiaoyu Li, Mei Zheng, Xi Lin, Guotao Lu, Dongming Su & Xiang Lu. (2019) Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin. Biochemical and Biophysical Research Communications 517:3, pages 538-544.
Crossref
Thomas Goedecke, Daniel R. Morales, Alexandra Pacurariu & Xavier Kurz. (2018) Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations. British Journal of Clinical Pharmacology 84:3, pages 419-433.
Crossref
Keith B. Hoffman, Andrea R. Demakas, Mo Dimbil, Nicholas P. Tatonetti & Colin B. Erdman. (2014) Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS). Drug Safety 37:11, pages 971-980.
Crossref
Chieko Ishiguro, Yasushi Hinomura, Keiko Uemura & Tsutomu Matsuda. (2014) Analysis of the Factors Influencing the Spontaneous Reporting Frequency of Drug Safety Issues Addressed in the FDA’s Drug Safety Communications, Using FAERS Data. Pharmaceutical Medicine 28:1, pages 7-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.